v3.26.1
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Research and development costs, net $ 202 $ 73 $ 402 $ 145
General and administrative costs 333 188 714 337
Total operating expenses (535) (261) (1,116) (482)
Operating loss (535) (261) (1,116) (482)
Other income (note 3d) 1,287 1,287
Financial income expenses net 50 (58) 18 (67)
Net income (loss) (485) 968 (1,098) 738
Equity in losses from investment in affiliate (38) (42)
Income (loss) before income tax (485) 930 (1,098) 696
Tax income 35 70
Net income (loss) (450) 930 (1,028) 696
Net loss attributable to non-controlling interest (40) (78)
Net income (loss) attributable to the Company (410) 930 (950) 696
Other comprehensive income (loss) (188) (1) (194) 10
Total comprehensive income (loss) (638) 929 (1,222) 706
Comprehensive loss attributable to non-controlling interests (42) (101)
Comprehensive income (loss) attributable to the Company $ (596) $ 929 $ (1,121) $ 706
Basic income (loss) per common stock $ (0.04) $ 0.09 $ (0.08) $ 0.07
Diluted income (loss) per common stock $ (0.04) $ 0.09 $ (0.08) $ 0.07
Weighted average common stock outstanding 11,246,252 9,893,849 11,246,252 9,756,066